pharmaphorum5 天
WCLC: MSD/Daiichi build case for phase 3 ADC for lung cancer
At the World Conference on Lung Cancer (WCLC) in San Diego, interim results from the dose optimisation part of the Ideate-Lung01 trial showed the benefit of the 12 mg/kg dose of the antibody-drug ...
pharmaphorum5 天
WCLC: Bayer, Boehringer face off on HER2 cancers
Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...